Logo
K

Kerecis

522 employees

Kerecis was founded by Fertram Sigurjonsson around the concept of using fish skin to heal damaged tissue. The company is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring. The Kerecis products are used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. The vision of Kerecis is to extend human life by supporting the body’s own ability to regenerate. The Kerecis mission is to become the world leader in regenerating damage of the human body by sustainably harnessing nature’s own remedies. In August 2023 Kerecis became Iceland’s first Unicorn when it sold to the Danish company Coloplast for $1.3 Billion.

Investor insights

Funding rounds participated in

$15M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Medical Equipment Manufacturing

Sectors

Medical Equipment Manufacturing

Date founded

2011

Funding rounds raised

Total raised

$15M

from 1 investors over 1 rounds

K

Kerecis raised $15M on August 21, 2022

Investors: Silicon Valley Bank

FAQ